Early explorers

MedImmune and UCSF collaborate on early stage translational research

Building on a partnership established in 2014, AstraZeneca plc (LSE:AZN; NYSE:AZN)'s MedImmune LLC biologics unit and the University of California San Francisco (UCSF) announced a new collaboration focused on basic and translational research in respiratory disease, inflammation and autoimmunity.

Through the original collaboration, MedImmune became

Read the full 453 word article

How to gain access

Continue reading with a
two-week free trial.